135 related articles for article (PubMed ID: 35761483)
1. Cancer Stem Cells and Chemoresistance in Ewing Sarcoma.
Dos Santos RP; Roesler R; Gregianin L; Brunetto AT; da Cunha Jaeger M; Lunardi Brunetto A; de Farias CB
Curr Stem Cell Res Ther; 2023; 18(7):926-936. PubMed ID: 35761483
[TBL] [Abstract][Full Text] [Related]
2. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
[TBL] [Abstract][Full Text] [Related]
3. C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells.
Gardiner JD; Abegglen LM; Huang X; Carter BE; Schackmann EA; Stucki M; Paxton CN; Lor Randall R; Amatruda JF; Putnam AR; Kovar H; Lessnick SL; Schiffman JD
Oncotarget; 2017 Apr; 8(16):26013-26026. PubMed ID: 28148901
[TBL] [Abstract][Full Text] [Related]
4. EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.
Robin TP; Smith A; McKinsey E; Reaves L; Jedlicka P; Ford HL
Mol Cancer Res; 2012 Aug; 10(8):1098-108. PubMed ID: 22723308
[TBL] [Abstract][Full Text] [Related]
5. Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach.
Asfa S; Toy HI; Arshinchi Bonab R; Chrousos GP; Pavlopoulou A; Geronikolou SA
Int J Environ Res Public Health; 2023 Jul; 20(13):. PubMed ID: 37444135
[TBL] [Abstract][Full Text] [Related]
6. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.
Awad O; Yustein JT; Shah P; Gul N; Katuri V; O'Neill A; Kong Y; Brown ML; Toretsky JA; Loeb DM
PLoS One; 2010 Nov; 5(11):e13943. PubMed ID: 21085683
[TBL] [Abstract][Full Text] [Related]
7. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
[TBL] [Abstract][Full Text] [Related]
8. Defining a Characteristic Gene Expression Set Responsible for Cancer Stem Cell-Like Features in a Sub-Population of Ewing Sarcoma Cells CADO-ES1.
Hotfilder M; Mallela N; Seggewiß J; Dirksen U; Korsching E
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563222
[TBL] [Abstract][Full Text] [Related]
9. The Ewing Family of Tumors Relies on BCL-2 and BCL-X
Heisey DAR; Lochmann TL; Floros KV; Coon CM; Powell KM; Jacob S; Calbert ML; Ghotra MS; Stein GT; Maves YK; Smith SC; Benes CH; Leverson JD; Souers AJ; Boikos SA; Faber AC
Clin Cancer Res; 2019 Mar; 25(5):1664-1675. PubMed ID: 30348635
[TBL] [Abstract][Full Text] [Related]
10. Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells.
Wang X; Liu Q; Hou B; Zhang W; Yan M; Jia H; Li H; Yan D; Zheng F; Ding W; Yi C; Hai Wang
PLoS One; 2013; 8(9):e73942. PubMed ID: 24040121
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T
Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
13. Ewing's sarcoma cancer stem cell targeted therapy.
Todorova R
Curr Stem Cell Res Ther; 2014 Jan; 9(1):46-62. PubMed ID: 24294922
[TBL] [Abstract][Full Text] [Related]
14. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells.
Riggi N; Suvà ML; De Vito C; Provero P; Stehle JC; Baumer K; Cironi L; Janiszewska M; Petricevic T; Suvà D; Tercier S; Joseph JM; Guillou L; Stamenkovic I
Genes Dev; 2010 May; 24(9):916-32. PubMed ID: 20382729
[TBL] [Abstract][Full Text] [Related]
15. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties.
Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
Int J Oncol; 2013 Feb; 42(2):453-9. PubMed ID: 23229446
[TBL] [Abstract][Full Text] [Related]
16. Poison-Exon Inclusion in DHX9 Reduces Its Expression and Sensitizes Ewing Sarcoma Cells to Chemotherapeutic Treatment.
Palombo R; Verdile V; Paronetto MP
Cells; 2020 Jan; 9(2):. PubMed ID: 32023846
[TBL] [Abstract][Full Text] [Related]
17. Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.
Santoro M; Menegaz BA; Lamhamedi-Cherradi SE; Molina ER; Wu D; Priebe W; Ludwig JA; Mikos AG
Tissue Eng Part A; 2017 Jan; 23(1-2):80-89. PubMed ID: 27923328
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer.
Yu J; Wang S; Zhao W; Duan J; Wang Z; Chen H; Tian Y; Wang D; Zhao J; An T; Bai H; Wu M; Wang J
Clin Cancer Res; 2018 May; 24(9):2148-2158. PubMed ID: 29437792
[No Abstract] [Full Text] [Related]
19. Transcriptome profiling of Ewing sarcomas - treatment resistance pathways and IGF-dependency.
Chen Y; Hesla AC; Lin Y; Ghaderi M; Liu M; Yang C; Zhang Y; Tsagkozis P; Larsson O; Haglund F
Mol Oncol; 2020 May; 14(5):1101-1117. PubMed ID: 32115849
[TBL] [Abstract][Full Text] [Related]
20. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
